EMA May Clash With Ethics Committees If It Asks For Earlier Neonatal Trials
Executive Summary
As the European Medicines Agency starts to address the findings of a report that questions the wisdom of granting lengthy deferrals for neonatal studies, an industry expert warns that by requiring such studies to be initiated earlier, the agency may come into conflict with ethics committees.